Peri has introduced the world’s first wearable device specifically designed for perimenopause, offering continuous biometric tracking and personalized insights. The innovation aims to empower women with objective health data, addressing a long-overlooked and under-researched phase of women’s health.
Addressing a Critical Gap in Women’s Health
Perimenopause is one of the most common yet least understood stages in women’s health, with symptoms ranging from hot flashes and sleep disturbances to anxiety and cognitive challenges. Despite its prevalence, the condition lacks standardized biomarkers and remains significantly under-researched.
Historically, gaps in clinical research and limited medical training have contributed to inadequate diagnosis and treatment, leaving many women without clear answers or effective care pathways.
Operational Details: Device and Technology
Peri’s wearable device is a compact, lightweight sensor worn under the breast, enabling continuous monitoring throughout daily activities, including sleep and exercise. This placement allows for more accurate detection of vasomotor symptoms such as hot flashes and night sweats, compared to traditional wrist or ring-based wearables.
The device is supported by an AI-driven platform that translates biometric data into actionable insights. Through its companion mobile app, users receive detailed analyses of symptom patterns, sleep quality, mood, and activity levels on a weekly and cyclical basis.
Priced at $449 with no subscription fees, the device is also eligible for FSA and HSA benefits, making it more accessible to users.
Economic Impact: Unlocking a New Health Tech Segment
Peri’s launch highlights the growing intersection of wearable technology and personalized healthcare. By creating one of the first large-scale datasets focused on perimenopause, the company is positioning itself at the forefront of a new category within health tech.
This data-driven approach has the potential to influence clinical research, improve treatment development, and drive innovation in a segment that has historically been overlooked by the healthcare industry.
Strategic Significance: Data-Driven Future of Women’s Healthcare
Beyond symptom tracking, Peri’s long-term vision focuses on building comprehensive health records that can identify early risk factors for conditions related to cardiovascular health, bone density, and cognitive function.
By leveraging AI and continuous monitoring, the company aims to shift healthcare from reactive treatment to proactive management. This approach not only empowers individuals but also has the potential to reshape how healthcare systems understand and address women’s health.
With its launch, Peri represents a significant step toward bridging the gender gap in medical research and delivering more inclusive, data-backed healthcare solutions.
Share your Details for subscribe